Does microalbuminuria predict diabetic nephropathy?

被引:123
作者
Tabaei, BP
Al-Kassab, AS
Ilag, LL
Zawacki, CM
Herman, WH
机构
[1] Univ Michigan, Med Ctr, Div Endocrinol, Taubman Ctr 3920,Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA
关键词
D O I
10.2337/diacare.24.9.1560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe risk factors associated with microalbuminuria (MA) in subjects with diabetes. investigate the predictive value of MA as a marker of risk for diabetic nephropathy (DN), and define risk factors associated with the development and progression of MA. RESEARCH DESIGN AND METHODS - We conducted a prospective longitudinal study of 23 diabetic subjects with persistent MA and 209 diabetic subjects without KA who attended diabetes clinics at the University of Michigan Medical Center in 1989 and 1990. Both ps were examined at baseline and after 7 years. At baseline, urinary albumin-to-creatinine groups ratios were studied in random, first morning, and 24-h urine samples. At follow-up, a 12-h overnight urine sample was collected and analyzed for albumin and creatinine. At baseline, MA was defined by at least two separate urine specimens with albumin-to-creatinine ratios between 30 and 299 mug albumin per milligram of creatinine. RESULTS - MA regressed in 56% of subjects with baseline MA without systematic application of corrective measures and developed in 16% of subjects without baseline MA. The predictive value positive of MA as a marker of risk for DN was 43%, and the predictive value negative,was 77%,. In the combined cohort, the incidence and progression of MA were significantly associated with poor glycemic control and duration of diabetes between 10 and 14 years. CONCLUSIONS - MA may not be as sensitive and specific a predictor of DN as previously suggested. Other markers of risk, for DN are needed for optimal clinical management.
引用
收藏
页码:1560 / 1566
页数:7
相关论文
共 36 条
  • [31] Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes
    Sikka, R
    Waters, J
    Moore, W
    Sutton, DR
    Herman, WH
    Aubert, RE
    [J]. DIABETES CARE, 1999, 22 (01) : 1 - 6
  • [32] Microalbuminuria and retinopathy in a diabetic population of Cameroon
    Sobngwi, E
    Mbanya, JC
    Moukouri, EN
    Ngu, KB
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 44 (03) : 191 - 196
  • [33] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    Turner, RC
    Holman, RR
    Cull, CA
    Stratton, IM
    Matthews, DR
    Frighi, V
    Manley, SE
    Neil, A
    McElroy, K
    Wright, D
    Kohner, E
    Fox, C
    Hadden, D
    Mehta, Z
    Smith, A
    Nugent, Z
    Peto, R
    Adlel, AI
    Mann, JI
    Bassett, PA
    Oakes, SF
    Dornan, TL
    Aldington, S
    Lipinski, H
    Collum, R
    Harrison, K
    MacIntyre, C
    Skinner, S
    Mortemore, A
    Nelson, D
    Cockley, S
    Levien, S
    Bodsworth, L
    Willox, R
    Biggs, T
    Dove, S
    Beattie, E
    Gradwell, M
    Staples, S
    Lam, R
    Taylor, F
    Leung, L
    Carter, RD
    Brownlee, SM
    Fisher, KE
    Islam, K
    Jelfs, R
    Williams, PA
    Williams, FA
    Sutton, PJ
    [J]. LANCET, 1998, 352 (9131) : 837 - 853
  • [34] VIBERTI GC, 1982, LANCET, V1, P1430
  • [35] Villar G, 1999, DIABETES METAB, V25, P246
  • [36] Progression of microalbuminuria to proteinuria in type 1 diabetes - Nonlinear relationship with hyperglycemia
    Warram, JH
    Scott, LJ
    Hanna, LS
    Wantman, M
    Cohen, SE
    Laffel, LMB
    Ryan, L
    Krolewski, AS
    [J]. DIABETES, 2000, 49 (01) : 94 - 100